Answers are grounded in this paper and cite their sources.
Molecular biochips accelerate tuberculosis diagnosis, suggesting potential for detecting drug-resistant strains.
The use of molecular biochips has been shown to considerably accelerate the laboratory diagnosis of tuberculosis and mycobacteriosis and, when used with an automated BACTEC MGIT 960 system, to obtain a result in 90% of the examinees within 10 days irrespective of bacillary burden. The biochips make it possible to study the genetic diversity of mutations and their combinations in the rpoB, katG, inhA, oxyR, and gyrA genes and to rapidly detect drug-resistant Mycobacterium strains and may serve as additional genetic markers for Mycobacterium tuberculosis strains circulating in the Moscow Region.
No takes yet. Share an insight, caveat, or question.
Litvinov et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: